You have 9 free searches left this month | for more free features.

Relapsed or Refractory Multiple Myeloma (1)

Not yet recruiting (1)

phase 1/phase 2 (1)

Hoffmann-La Roche (1)

carfilzomib (1)

daratumumab (1)

forimtamig (1)

drug (1)

Industry (1)

Interventional (1)

forimtamig

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Sep 20, 2023